LYTIR

Insider · SEC Form 4 · President, IBU

Giles Richard Platford

Filed with the SEC as Platford Giles Richard; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $1.7M of TAK. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.7M in total.Aug: Insider sales $532KNov: Insider sales $1.2MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.7M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. TAKSold: TAKEDA PHARMACEUTICAL CO LTD Nov 4, 2026 55,617 shares filed Nov 5, 2026 270,253 shares held directly after, as filed filing $1.2M
  2. TAKSold: TAKEDA PHARMACEUTICAL CO LTD Aug 10, 2026 31,083 shares filed Aug 12, 2026 315,838 shares held directly after, as filed filing $532K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • TAK: grant or award (code A), 1 entry, Jul 1, 2026
Code A
A grant or award from the company, such as stock given as pay.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.